ReviewJNCI cancer spectrum2023

Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors: existing and emerging differences.

Stephen Johnston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.